Atara Biotherapeutics Stock Forecast

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Atara Biotherapeutics stock ranges from a low of $17 to a high of $25. The average analyst price target of $21 forecasts a 46.55% increase in the stock price over the next year.

Price Target: $21.00 (+46.55%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$17	$21	$25	$25
Change	+18.63%	+46.55%	+74.46%	+74.46%

* Price targets were last updated on Mar 11, 2025.

Analyst Ratings

The average analyst rating for Atara Biotherapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	2	2	2	2	2	2
Buy	1	1	1	1	1	0
Hold	2	2	2	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	0
Total	6	6	6	6	6	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
John Newman Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $17	Strong Buy	Maintains	$17	+18.63%	Mar 11, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jan 28, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Jan 22, 2025
John Newman Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $21 → $17	Strong Buy	Maintains	$21 → $17	+18.63%	Jan 17, 2025
Tony Butler Rodman & Renshaw	Rodman & Renshaw	Strong Buy Initiates $25	Strong Buy	Initiates	$25	+74.46%	Dec 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

123.54M

from 128.94M

-4.19%

from 128.94M

Revenue Next Year

59.10M

from 123.54M

-52.16%

from 123.54M

EPS This Year

2.14

from -11.41

EPS Next Year

-0.28

from 2.14

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	20.34M	63.57M	8.57M	128.94M	123.54M	59.10M
Revenue Growth	-	-	212.55%	-86.52%	1,404.02%	-4.19%	-52.16%
EPS	-103.63	-90.78	-55.96	-65.19	-11.41	2.14	-0.28
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	6.71	-
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	130.2M	76.7M
Avg	123.5M	59.1M
Low	116.8M	43.3M

Revenue Growth

Revenue Growth	2025	2026
High	1.0%	-38.0%
Avg	-4.2%	-52.2%
Low	-9.4%	-64.9%

EPS Forecast

EPS	2025	2026
High	2.59	0.91
Avg	2.14	-0.28
Low	1.69	-0.95

EPS Growth

EPS Growth	2025	2026
High	-	-57.3%
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.